MARCH5-dependent degradation of MCL1/NOXA complexes defines susceptibility to antimitotic drug treatment

Manuel D. Haschka, Gerlinde Karbon, Claudia Soratroi, Katelyn L. O’Neill, Xu Luo, Andreas Villunger

Research output: Contribution to journalArticlepeer-review

10 Scopus citations

Fingerprint

Dive into the research topics of 'MARCH5-dependent degradation of MCL1/NOXA complexes defines susceptibility to antimitotic drug treatment'. Together they form a unique fingerprint.

Medicine & Life Sciences